RESPIRATORY INFECTION VIRUS
Clinical trials for RESPIRATORY INFECTION VIRUS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY INFECTION VIRUS trials appear
Sign up with your email to follow new studies for RESPIRATORY INFECTION VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One shot to stop RSV: landmark trial for indigenous kids
Prevention Not yet recruitingThis study tests whether a single dose of nirsevimab, an antibody that targets RSV, can prevent respiratory infections in Aboriginal and Torres Strait Islander children aged 6 months. Around 1,000 children will be randomly assigned to receive either the antibody or standard care.…
Matched conditions: RESPIRATORY INFECTION VIRUS
Phase: PHASE4 • Sponsor: Menzies School of Health Research • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Nasal shields aim to stop COVID and flu before they start
Prevention Not yet recruitingThis study tests two nasal protective devices (Noseguard and Noseguard Night) in 2000 adults to see if they can reduce the risk of catching respiratory infections like COVID-19 and influenza. Participants will use the devices as directed for 8 weeks, and researchers will track in…
Matched conditions: RESPIRATORY INFECTION VIRUS
Phase: NA • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC